Related by context. Frequent words. (Click for all words.) 62 Phase Ib clinical 61 Initiate Phase 60 relapsed refractory multiple myeloma 60 Phase 1b 60 By FRAN SYPEK 60 phase Ib 60 Clinical Trials Update 59 multicenter Phase 59 IMC #B 59 placebo controlled Phase 58 phase IIa 58 registrational trial 58 Phase 2a trial 58 dose escalation trial 58 phase IIb clinical 57 Phase 2a clinical 57 IIa trial 57 Clinical Trial Results 57 Initiates Phase 57 phase IIb 57 Phase Ib 57 Phase 2b clinical trials 57 Phase 1a 57 II Clinical Trial 57 randomized Phase III 57 phase IIa clinical 56 multi kinase inhibitor 56 here http:/blogs.nashuatelegraph.com/webnotes/#Culminating 56 INCB# [001] 56 phase 2a 56 PRECiSE 56 elotuzumab 56 Phase 2b study 56 BY OWNER 56 Inovio clinical 56 Pivotal Phase 56 Phase II 56 multicenter randomized double 56 PSN# [002] 56 deforolimus 56 Lu AA# 56 Tesetaxel 56 MKC# 55 Phase 1b clinical 55 CORT # 55 Phase IIa trial 55 IMC A# 55 Pharming website http:/www.pharming.com 55 HGS ETR1 55 multiple ascending dose 55 vascular disrupting agent 55 Phase IIb clinical 55 Phase IIB 55 RGB # 55 Phase 1b trial 55 8 Cyl 55 Phase IIb trials 55 Metastatic Melanoma 55 Phase 2b clinical 55 Phase 2b trial 55 budesonide MMX 54 liposomal formulation 54 EndoTAG TM -1 54 Traficet EN 54 http:/www.mheducation.com 54 CCX# 54 NVA# 54 SCH # 54 metastatic hormone refractory 54 Phase 2a 54 GVAX R 54 placebo controlled randomized 54 Completes Enrollment 54 Phase IIa clinical 54 PEG SN# 54 forodesine 54 ATL# [001] 54 generation HCV protease 54 polymerase inhibitor 53 tanespimycin 53 Daclizumab 53 Dapagliflozin 53 IIa clinical trial 53 tolerated dose MTD 53 Amrubicin 53 Phase IIb 53 registrational 53 Phase 2b 53 drug conjugate 53 Carfilzomib 53 Phase III 53 BCX# 53 randomized multicenter 53 Phase III Clinical Trial 53 single ascending dose 53 information visit www.infor.com 53 axitinib 53 Azedra 53 MEK inhibitor 53 CR# vcMMAE 53 KRN#